Shares of three U.S. corporate giants that must have in your portfolio are: APH, APP, PM.
Amphenol Corporation (APH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, APH's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Explore Amphenol's (APH) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Here is how Amphenol (APH) and CI&T Inc. (CINT) have performed compared to their sector so far this year.
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ODD, CRS, HRTG, APH, MRX.
I reiterate a Buy rating on Amphenol Corporation stock with a one-year target price of $87 per APH share, driven by strong product demands and robust financial performance. Amphenol posted 33% organic revenue growth and 57.5% adjusted EPS growth, driven by strong market demands in the IT datacom market. The acquisition of LifeSync aligns with Amphenol's M&A strategy, potentially adding $100 million in revenue from the medical device market.
Does Amphenol (APH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Amphenol (APH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
APH is benefiting from strategic acquisitions and increased demand in AI and aerospace, making it an attractive investment despite a premium valuation.
Amphenol shines in first-quarter 2025 with record Communications Solutions sales, though aerospace weakness and rising capex may challenge its growth trajectory.
Amphenol's Q1 results were exceptional, with earnings and revenues both growing far faster than expected. The company also offered Q2 guidance that was much higher than prior street estimates despite the unsettled macroeconomic picture. Amphenol has meaningful China exposure, and would also face downside if the AI spending boom slows.